NEW YORK (360Dx) — Swiss diagnostics firm Quotient said on Wednesday that it has received CE marking for the first immunohematology (IH) microarray designed to run on its MosaiQ high-throughput automated testing platform.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.